Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Søkilde R[au]:

Search results

Items: 22

1.

Refinement of breast cancer molecular classification by miRNA expression profiles.

Søkilde R, Persson H, Ehinger A, Pirona AC, Fernö M, Hegardt C, Larsson C, Loman N, Malmberg M, Rydén L, Saal L, Borg Å, Vallon-Christerson J, Rovira C.

BMC Genomics. 2019 Jun 17;20(1):503. doi: 10.1186/s12864-019-5887-7.

2.

HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503.

Gorbatenko A, Søkilde R, Sorensen EE, Newie I, Persson H, Morancho B, Arribas J, Litman T, Rovira C, Pedersen SF.

Sci Rep. 2019 Mar 4;9(1):3352. doi: 10.1038/s41598-019-39733-x.

3.

Frequent miRNA-convergent fusion gene events in breast cancer.

Persson H, Søkilde R, Häkkinen J, Pirona AC, Vallon-Christersson J, Kvist A, Mertens F, Borg Å, Mitelman F, Höglund M, Rovira C.

Nat Commun. 2017 Oct 5;8(1):788. doi: 10.1038/s41467-017-01176-1.

4.

Preparation of highly multiplexed small RNA sequencing libraries.

Persson H, Søkilde R, Pirona AC, Rovira C.

Biotechniques. 2017 Aug 1;63(2):57-64. doi: 10.2144/000114574.

5.

HER2-encoded mir-4728 forms a receptor-independent circuit with miR-21-5p through the non-canonical poly(A) polymerase PAPD5.

Newie I, Søkilde R, Persson H, Jacomasso T, Gorbatenko A, Borg Å, de Hoon M, Pedersen SF, Rovira C.

Sci Rep. 2016 Oct 18;6:35664. doi: 10.1038/srep35664.

6.

GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation.

Bang-Berthelsen CH, Holm TL, Pyke C, Simonsen L, Søkilde R, Pociot F, Heller RS, Folkersen L, Kvist PH, Jackerott M, Fleckner J, Vilién M, Knudsen LB, Heding A, Frederiksen KS.

Inflamm Bowel Dis. 2016 Sep;22(9):2078-97. doi: 10.1097/MIB.0000000000000847.

PMID:
27542128
7.

miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.

Thomsen KG, Terp MG, Lund RR, Søkilde R, Elias D, Bak M, Litman T, Beck HC, Lyng MB, Ditzel HJ.

Oncotarget. 2015 Oct 6;6(30):29224-39. doi: 10.18632/oncotarget.4942.

8.

Passenger strand loading in overexpression experiments using microRNA mimics.

Søkilde R, Newie I, Persson H, Borg Å, Rovira C.

RNA Biol. 2015;12(8):787-91. doi: 10.1080/15476286.2015.1020270.

9.

PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.

Boele J, Persson H, Shin JW, Ishizu Y, Newie IS, Søkilde R, Hawkins SM, Coarfa C, Ikeda K, Takayama K, Horie-Inoue K, Ando Y, Burroughs AM, Sasaki C, Suzuki C, Sakai M, Aoki S, Ogawa A, Hasegawa A, Lizio M, Kaida K, Teusink B, Carninci P, Suzuki H, Inoue S, Gunaratne PH, Rovira C, Hayashizaki Y, de Hoon MJ.

Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11467-72. doi: 10.1073/pnas.1317751111. Epub 2014 Jul 21.

10.

Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.

Rask L, Balslev E, Søkilde R, Høgdall E, Flyger H, Eriksen J, Litman T.

Cell Oncol (Dordr). 2014 Jun;37(3):215-27. doi: 10.1007/s13402-014-0176-6. Epub 2014 Jul 16.

PMID:
25027758
11.

The HER2-encoded miR-4728-3p regulates ESR1 through a non-canonical internal seed interaction.

Newie I, Søkilde R, Persson H, Grabau D, Rego N, Kvist A, von Stedingk K, Axelson H, Borg Å, Vallon-Christersson J, Rovira C.

PLoS One. 2014 May 14;9(5):e97200. doi: 10.1371/journal.pone.0097200. eCollection 2014.

12.

Efficient identification of miRNAs for classification of tumor origin.

Søkilde R, Vincent M, Møller AK, Hansen A, Høiby PE, Blondal T, Nielsen BS, Daugaard G, Møller S, Litman T.

J Mol Diagn. 2014 Jan;16(1):106-15. doi: 10.1016/j.jmoldx.2013.10.001. Epub 2013 Nov 5.

PMID:
24211363
13.

The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa.

Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beissbarth T, Ried T, Litman T.

Clin Cancer Res. 2012 Sep 15;18(18):4919-30. Epub 2012 Jul 31.

14.

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study.

Lyng MB, Lænkholm AV, Søkilde R, Gravgaard KH, Litman T, Ditzel HJ.

PLoS One. 2012;7(5):e36170. doi: 10.1371/journal.pone.0036170. Epub 2012 May 18.

15.

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.

Gravgaard KH, Lyng MB, Laenkholm AV, Søkilde R, Nielsen BS, Litman T, Ditzel HJ.

Breast Cancer Res Treat. 2012 Jul;134(1):207-17. doi: 10.1007/s10549-012-1969-9.

PMID:
22294488
16.

MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.

Husted S, Søkilde R, Rask L, Cirera S, Busk PK, Eriksen J, Litman T.

Mol Pharm. 2011 Dec 5;8(6):2055-62. doi: 10.1021/mp200255d. Epub 2011 Sep 21.

PMID:
21899346
17.

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).

Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT, Lauenborg B, Zibert JR, Krejsgaard T, Bonefeld CM, Søkilde R, Gjerdrum LM, Labuda T, Mathiesen AM, Grønbæk K, Wasik MA, Sokolowska-Wojdylo M, Queille-Roussel C, Gniadecki R, Ralfkiaer E, Geisler C, Litman T, Woetmann A, Glue C, Røpke MA, Skov L, Odum N.

Blood. 2011 Nov 24;118(22):5891-900. doi: 10.1182/blood-2011-06-358382. Epub 2011 Aug 24.

18.

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.

Hansen ML, Woetmann A, Krejsgaard T, Kopp KL, Søkilde R, Litman T, Straten PT, Geisler C, Wasik MA, Odum N, Eriksen KW.

Mol Immunol. 2011 Sep;48(15-16):2087-93. doi: 10.1016/j.molimm.2011.07.008. Epub 2011 Aug 2.

PMID:
21813181
19.

MicroRNA expression profiling of the porcine developing brain.

Podolska A, Kaczkowski B, Kamp Busk P, Søkilde R, Litman T, Fredholm M, Cirera S.

PLoS One. 2011 Jan 6;6(1):e14494. doi: 10.1371/journal.pone.0014494.

20.

Global microRNA analysis of the NCI-60 cancer cell panel.

Søkilde R, Kaczkowski B, Podolska A, Cirera S, Gorodkin J, Møller S, Litman T.

Mol Cancer Ther. 2011 Mar;10(3):375-84. doi: 10.1158/1535-7163.MCT-10-0605. Epub 2011 Jan 20.

21.

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients.

Nielsen BS, Jørgensen S, Fog JU, Søkilde R, Christensen IJ, Hansen U, Brünner N, Baker A, Møller S, Nielsen HJ.

Clin Exp Metastasis. 2011 Jan;28(1):27-38. doi: 10.1007/s10585-010-9355-7. Epub 2010 Oct 31.

22.

Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing.

Willenbrock H, Salomon J, Søkilde R, Barken KB, Hansen TN, Nielsen FC, Møller S, Litman T.

RNA. 2009 Nov;15(11):2028-34. doi: 10.1261/rna.1699809. Epub 2009 Sep 10.

Supplemental Content

Loading ...
Support Center